Risk of severe frostbite associated with moderate COVID-19; Lowering blood pressure can prevent fractures With Reuters


© Reuters. TRAINING PHOTO: A medical worker draws blood from a saleswoman during an active coronavirus antiretroviral test (COVID-19) at Sopocachi Market in La Paz, Bolivia, December 26, 2020. REUTERS / David Mercado

Author Nancy Lapid

(Reuters) – The following is a summary of a recent study on COVID-19. It includes research that allows them to continue their studies to confirm their findings and what should not be confirmed and to peer review.

Dangerous blood clotting can occur in low COVID-19

A European study found a high risk of developing venous thromboembolism (VTE) in COVID-19 patients who were not severely ill. Blood pressure is already associated with high COVID-19. The researchers analyzed 2,292 patients who came to emergency hospitals with COVID-19 mild or moderate but without VTE. Four weeks later, VTE was introduced in about 1 in 200 outpatients and in about 5 out of every 200 patients, researchers said Friday at Thrombosis Research https: // awareness of these risks, “especially for patients with essential COVID-19 who need medical attention.”

Those who use very little blood prevent freezing in a low COVID-19

In-hospital patients, high-dose COVID-19 patients with high d-dimer proteins in their blood – indicating a higher risk of hypertension – high heparin-containing blood thinner (LMWH) drugs have significantly reduced the side effects. hemorrhage and death, according to a study conducted at the hospital. The incidence of venous thromboembolism (VTE) or death was 28.7% in the general treatment group, compared with 41.9% in patients receiving standardized doses. After calculating various patient complications, which reduced 32% of the risk of high heparin levels, the researchers said Monday in a report published in JAMA Internal Medicine https: // , ”said research leader Dr. Alex Spyropoulos of Feinstein Institutes for Medical Research in New York. “We were able to confirm … that d-dimensers more than four times higher than the maximum limit can detect a group at high risk of hospitalization of COVID-19 patients – and to provide heparin in these active patients,” Spyropoulos said. “This is trying to change now.”

Click the Reuters image https://tmsnrt.rs/3c7R3Bl on the development vaccine.

Disclaimer: Fusion Media I want to remind you that the content on this page is not necessarily accurate or accurate. All CFDs (stocks, indexes, futures) and futures prices are not exchanged but are market makers, so the prices may not be accurate and may differ from the actual market price, meaning that prices are indicative and not marketable. As a result, Fusion Media will not be liable for any losses you may incur as a result of using this feature.

Fusion Media or anyone involved with Fusion Media will not accept any loss or damage as a result of reliance on the information including information, documentation, charts and purchases / sales contained on this page. Please know more about the risks and costs of trading the financial markets, this is one of the most risky financial options possible.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *